Effect of oral immunotherapy on nasal blockage in experimental allergic rhinitis

Journal of Pharmacological Sciences

Volumn 98, Issue 4, 2005, Pages 380-387

  Nabe, Takeshi ^a   Kubota, Kayoko ^a   Terada, Tetsuya ^a,b   Takenaka, Hiroshi ^b   Kohno, Shigekatsu ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Allergic rhinitis; Animal model; Nasal blockage; Oral immunotherapy; Pollenosis

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY; LEUKOTRIENE D4; POLLEN EXTRACT;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; DRUG EFFICACY; IMMUNOTHERAPY; MALE; NONHUMAN; NOSE MUCOSA; POLLEN ALLERGY; SNEEZING; TREATMENT WITHDRAWAL;

EID: 24744435852     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0050372     Document Type: Article

References (25)

1. Naclerio RM. Allergic rhinitis. N Eng J Med. 1991;325:860-869.
2. 1-receptor antagonists: clinical pharmacology and therapeutics. J Allergy Clin Immunol. 1989;84:845-861.
3. Van Oosten MCM, Pelikan HMP, Ossekoppele R, Pelikan Z. Pharmacologic modulation of the cytologic changes in the nasal secretions (NS) accompanying the immediate nasal response to allergen challenge [INR]. J Allergy Clin Immunol. 1997;99:S445.
4. Pelikan Z, Van Oosten MCM, Pelikan HMP. Pharmacologic modulation of the cytologic changes in the nasal secretions (NS) accompanying the late nasal response to allergen challenge [LNR]. Allergy Clin Immunol Int. 1997;261 Suppl:956.
5. Fouke JM, Jackson AC. Acoustic rhinometry: effects of decongestants and posture on nasal patency. J Lab Clin Med. 1992;19:371-376.
6. Malm L, Wihl JA. Intranasal beclomethasone dipropionate in vasomotor rhinitis. Acta Allergol. 1976;31:227-238.
7. Graf P, Juto JE. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling. Rhinology. 1995;33:14-17.
8. Waddell AN, Patel SK, Toma AG, Maw AR. Intranasal steroid sprays in the treatment of rhinitis: is one better than another? J Laryngol Otol. 2003;117:843-845.
9. Valovirta E. Preventive capacity of subcutaneous immunotherapy. Curr Opin Allergy Clin Immunol. 2002;2:553-556.
10. Stewart GE, Lockey RF. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol. 1992;90:567-578.
11. Canonica GW, Passalacqua G. Noninjection routes of immunotherapy. J Allergy Clin Immunol. 2003;111:437-448.
12. Nabe T, Shimizu K, Mizutani N, Saeki Y, Yamamura H, Takenaka H, et al. A new model of experimental allergic rhinitis using Japanese cedar pollen in guinea pigs. Jpn J Pharmacol. 1997;75:243-251.
13. Nabe T, Mizutani N, Shimizu K, Takenaka H, Kohno S. Development of pollen-induced allergic rhinitis with early and late phase nasal blockage in guinea pigs. Inflamm Res. 1998;47:369-374.
14. Mizutani N, Nabe T, Sasaki K, Takenaka H, Kohno S. Nasal hyperresponsiveness to histamine induced by repetitive exposures to cedar pollen in guinea-pigs. Eur Respir J. 1999;14:1368-1375.
15. 4 in an experimental allergic rhinitis model: contribution of dilated mucosal blood vessels. Jpn J Pharmacol. 2001;86:170-182.
16. Terada T, Nabe T, Mizutani N, Takenaka H, Kohno S. Effect of oral antigen administration on nasal blockage in experimental allergic rhinitis in guinea pigs. Inflamm Res. 2002;51:206-212.
17. Nabe T, Shinoda N, Yamashita K, Yamada M, Yamamura H, Kohno S. Comparative studies on nebulizers for antigen inhalation in experimental asthma. Allergol Int. 1997;46:261-267.
18. Bensadoun A, Weinstein D. Assay of protein in the presence of interfering materials. Anal Biochem. 1976;70:241-250.
19. Pennock BE, Cox CP, Rogers RM, Cain WA, Wells JH. A noninvasive technique for measurement of changes in specific airway resistance. J Appl Physiol. 1979;46:399-406.
20. Mosbech H, Dreborg S, Madsen F, Ohlsson H, Stahl Skov P, Taudorf E, et al. High dose grass pollen tablets used for hyposensitization in hay fever patients. A one-year double blind placebo-controlled study. Allergy. 1987;42:451-455.
21. Van Deusen MA, Angelini BL, Cordoro KM, Seiler BA, Wood L, Skoner DP. Efficacy and safety of oral immunotherapy with short ragweed extract. Ann Allergy Asthma Immunol. 1997;78:573-580.
22. 2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis. Inflamm Res. 2001;50:466-473.
23. Mizutani N. [Studies on the experimental allergic rhinitis induced by Japanese cedar pollen - Role of cysteinyl leukotrienes in nasal allergic symptoms]. Yakugaku Zasshi. 2003;123:1-8. (text in Japanese with English abstract)
24. Gerrelds IM, de Graaf-in't Veld C, Gerth van Wijk R, Zijlstra FJ. Nasal hyperreactivity and inflammation in allergic rhinitis. Med Inflamm. 1996;5:79-94.
25. Imai A, Nabe T, Mizutani N, Sakurai H, Takenaka H, Kohno S. Involvement of nitric oxide in pollen-induced biphasic nasal blockage in sensitized guinea pigs. Eur J Pharmacol. 2001;423:63-70.